39 results on '"Zhao, Xie-Lan"'
Search Results
2. A validated UPLC–MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma
3. Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia
4. Role of HMGB1 in regulation of STAT3 expression in CD4+ T cells from patients with aGVHD after allogeneic hematopoietic stem cell transplantation
5. Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients
6. Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens
7. Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)
8. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia
9. TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients
10. CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
11. Chidamide acts on the histone deacetylase‐mediated miR ‐34a/Bcl‐2 axis to regulate NB4 cell line proliferation and apoptosis
12. Down-regulating NQO1 promotes cellular proliferation in K562 cells via elevating DNA synthesis
13. Effects of Trough Concentration and Solute Carrier Polymorphisms on Imatinib Efficacy in Chinese Patients with Chronic Myeloid Leukemia
14. Changing Treatment May Affect the Predictive Ability of European Treatment Outcome Study Scoring for the Prognosis of Patients with Chronic Myeloid Leukemia
15. Meta-Analysis of the Effect of MDR1 C3435T Polymorphism on Cyclosporine Pharmacokinetics
16. Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemia
17. Chidamide acts on the histone deacetylase‐mediated miR‐34a/Bcl‐2 axis to regulate NB4cell line proliferation and apoptosis
18. High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia
19. Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
20. Role of HMGB1 in regulation of STAT3 expression in CD4 + T cells from patients with aGVHD after allogeneic hematopoietic stem cell transplantation
21. PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia
22. Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma.
23. Trough concentration and ABCG2polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
24. Hypothesizing that histone deacetylase inhibitors can be used to reverse multiple drug resistance
25. Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjects
26. Role of Lyn Kinase in Imatinib-resistant Chronic Myelogenous Leukemia.
27. Expression of DNA-dependent Protein Kinase Catalytic Subunit in Adult Acute Leukemia and Its Significance.
28. Inhibitory Effect of Daunorubicin Enhanced by PDTC on Drug-resistant Leukemic Cells in vitro.
29. Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis
30. [Role of Lyn kinase in imatinib-resistant chronic myelogenous leukemia].
31. [Expression of DNA-dependent protein kinase catalytic subunit in adult acute leukemia and its significance].
32. [Expression of angiotensin-II type 1 receptor at1 mRNA in myeloid leukemia].
33. [Therapeutic effect of priming induction regimen of CAG for newly diagnosed acute myeloid leukemia in elderly patients].
34. [Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia].
35. [Clinical significance of NF-kappaB continual activity and expression of WT1 and MDR1 in acute nonlymphocytic leukemia].
36. [Renin angiotensin system in bone marrow of patients with aplastic anemia].
37. [Inhibitory effect of daunorubicin enhanced by PDTC on drug-resistant leukemic cells in vitro].
38. [Renin angiotensin system in local bone marrow].
39. [Clinical analysis of 282 patients with non-Hodgkin's lymphoma].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.